Mofitt Cancer Center

Tampa, Florida 33612

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer — Completed